Publications by authors named "Ian Ramshaw"

Claim this Profile
I
Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties.
Michael Frese, Eva Lee, Maximilian Larena, Pek Siew Lim, Sudha Rao, Ian Ramshaw

J Virol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
Nicholas P West, Scott A Thomson, James A Triccas, C Jill Medveczky, Ian A Ramshaw

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Duncan B Sutherland, Charani Ranasinghe, Matthias Regner, Simon Phipps, Klaus I Matthaei, Ian A Ramshaw

Immunol Cell Biol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.
Charani Ranasinghe, Fiona Eyers, John Stambas, David B Boyle, Ian A Ramshaw

Vaccine· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus-1 vaccine design: where do we go now?
Danushka K Wijesundara, Ronald J Jackson, Ian A Ramshaw, Charani Ranasinghe

Immunol Cell Biol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mousepox experience. An interview with Ronald Jackson and Ian Ramshaw on dual-use research. Interview by Michael J. Selgelid and Lorna Weir.
Ronald Jackson, Ian Ramshaw

EMBO Rep· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.
Charani Ranasinghe, Ian A Ramshaw

Expert Rev Vaccines· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity.
Charani Ranasinghe, Ian A Ramshaw

Eur J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy.
Stephanie L Day, Ian A Ramshaw, Alistair J Ramsay, Charani Ranasinghe

J Immunol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.
Erik Rollman, Miranda Z Smith, Andrew G Brooks, Damian F J Purcell, Bartek Zuber, Ian A Ramshaw

J Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting 4-1BB costimulation for enhancing antiviral vaccination.
Jodie M Harrison, Edward M Bertram, Ian A Ramshaw

Viral Immunol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.
Charani Ranasinghe, Stephen J Turner, Craig McArthur, Duncan B Sutherland, Jee-Hye Kim, Ian A Ramshaw

J Immunol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.
Robert De Rose, C Jane Batten, Miranda Z Smith, Caroline S Fernandez, Viv Peut, Ian A Ramshaw

J Virol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2.
Michael S Rolph, Timothy R Young, Bennett O V Shum, Cem Z Gorgun, Carsten Schmitz-Peiffer, Ian A Ramshaw

J Immunol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
Jodie M Harrison, Edward M Bertram, David B Boyle, Barbara E H Coupar, Charani Ranasinghe, Ian A Ramshaw

Vaccine· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-boost strategies in DNA vaccines.
C Jane Dale, Scott Thomson, Robert De Rose, Charani Ranasinghe, C Jill Medveczky, Ian A Ramshaw

Methods Mol Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines: implications for future trials.
Robert De Rose, Mark T Sullivan, C Jane Dale, Anthony D Kelleher, Sean Emery, Ian A Ramshaw

Hum Vaccin· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
Charani Ranasinghe, Jill C Medveczky, Donna Woltring, Ke Gao, Scott Thomson, Ian A Ramshaw

Vaccine· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines, skin, and smallpox-a new link to an antimicrobial Peptide.
Jodie M Harrison, Ian A Ramshaw

Immunity· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
Barbara E H Coupar, Damian F J Purcell, Scott A Thomson, Ian A Ramshaw, Stephen J Kent

Vaccine· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissue.
Michelle F Solomon, Ian A Ramshaw, Charmaine J Simeonovic

Immunol Cell Biol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Stephen J Kent, C Jane Dale, Charani Ranasinghe, Ivan Stratov, Robert De Rose, Ian A Ramshaw

Vaccine· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.
Scott A Thomson, Angel B Jaramillo, Maryanne Shoobridge, Kerrie J Dunstan, Beth Everett, Ian A Ramshaw

Vaccine· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.
Samantha J Robbins, Ronald J Jackson, Frank Fenner, Sandra Beaton, Jill Medveczky, Ian A Ramshaw

Antiviral Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques.
Joko Pamungkas, Robert De Rose, Diah Iskandriati, Rachmitasari Noviana, Yasmina Paramastri, Ian A Ramshaw

AIDS Res Hum Retroviruses· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis